ArticleBMJ open2025

EXtending Omalizumab Treatment Intervals in patients with Chronic spontaneous urticaria (EXOTIC): protocol of a multicentre, randomised, open-label, non-inferiority trial.

Ditte Georgina Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.